Open AccessTrial in Progress: A Phase 2, Single-Arm, Open-Label Study of Itacitinib (ITA) for the Prevention of Chimeric Antigen Receptor (CAR) T-Cell–Induced Cytokine Release Syndrome (CRS)
Author(s) -
Jae H. Park,
Matthew J. Frigault,
Richard T. Maziarz,
Ahmad Naim,
Lea Burke,
Chuan Tian,
David L. Porter
Publication year - 2020
Publication title -
biology of blood and marrow transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.301
H-Index - 120
eISSN - 1523-6536
pISSN - 1083-8791
DOI - 10.1016/j.bbmt.2019.12.436
Subject(s) - medicine , cytokine release syndrome , tocilizumab , chimeric antigen receptor , immunotherapy , clinical trial , cytokine , immunology , oncology , immune system , pharmacology , rheumatoid arthritis
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom